Skip to main content
Clinical Trials/EUCTR2004-002966-39-GB
EUCTR2004-002966-39-GBActive, not recruitingNot Applicable

A Double-blind randomised controlled trial to compare buscopan versus placebo as an adjunct to colonoscopy

Sheffield Teaching Hospitals NHS Foundation Trust0 sites300 target enrollmentStarted: January 8, 2007Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • all patients due to undergo colonoscopy at the Northern General Hospital in Sheffield will be invited to take part in this study. This will include patients requesting Midazolam (intravenous sedation) or Entonox (inhaled analgesia) during their colonoscopy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • allergy to buscopan; previous bowel resection; glaucoma; obstructive uropathy; autonomic dysfunction; myasthenia gravis; concurrent anticholinergic medication;l inability to consent or understand or read English.

Investigators

Similar Trials

A Double-blind randomised controlled trial... | Clinical Trial